Estrogens are steroid hormones produced primarily by the ovaries that regulate development and function of the female reproductive system, secondary sexual characteristics, the menstrual cycle, bone metabolism, and numerous other tissues. Estradiol is the predominant biologically active estrogen during the reproductive years.
Estrogens are a group of steroid hormones with major roles in the development and function of the female reproductive system, regulation of the ovarian and menstrual cycles, development of secondary sexual characteristics, maintenance of bone, and physiological regulation of numerous other tissues. The ovaries are the principal source of circulating estrogens during the reproductive years.
The three major naturally occurring estrogens are estradiol (E2), estrone (E1), and estriol (E3). Estradiol is the predominant and most biologically potent circulating estrogen during the reproductive years. Estrone becomes relatively more important after menopause, while estriol is produced in large quantities during pregnancy.
Within the ovary, estrogen synthesis depends on coordinated activity between theca cells and granulosa cells of developing ovarian follicles. This relationship is regulated primarily by luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and is commonly described by the two-cell, two-gonadotropin model.
| Estrogen | Abbreviation | Major Physiological Context |
|---|---|---|
| Estradiol | E2 | Predominant estrogen during reproductive years |
| Estrone | E1 | Relatively important after menopause and in peripheral estrogen production |
| Estriol | E3 | Produced in large quantities during pregnancy |
17β-estradiol is the principal estrogen produced by the ovaries during the reproductive years. It is synthesized mainly by granulosa cells of developing follicles from androgen precursors supplied by theca interna cells.
Estradiol influences reproductive organs, hypothalamic-pituitary regulation, bone, breast tissue, cardiovascular tissues, skin, brain, liver, and other organs.
Estrone is a naturally occurring estrogen that can be produced through peripheral conversion of androgen precursors, particularly androstenedione.
After menopause, when ovarian estradiol production declines markedly, peripheral formation of estrone becomes a relatively important source of estrogenic activity.
Estriol is a weaker estrogen that becomes particularly important during pregnancy.
Its production depends substantially on coordinated steroid metabolism involving the fetus and placenta.
The ovaries are paired reproductive and endocrine organs located within the female pelvis. Their endocrine function changes cyclically in response to gonadotropins from the anterior pituitary.
Developing follicles, the corpus luteum, and ovarian stromal cells contribute to steroid hormone production at different stages of the ovarian cycle.
Ovarian follicles contain an oocyte surrounded by specialized somatic cells. As follicles develop, granulosa cells proliferate and surrounding stromal cells differentiate into the theca layers.
The theca interna and granulosa cells cooperate in estrogen synthesis.
The theca interna is a vascular endocrine layer surrounding the granulosa compartment of an antral follicle. Theca interna cells express LH receptors and possess enzymes required for androgen synthesis from cholesterol-derived steroid precursors.
These androgens provide substrates for estrogen synthesis in granulosa cells.
Granulosa cells surround the developing oocyte and follicular antrum. They respond primarily to FSH during much of follicular development.
FSH promotes expression of aromatase, the enzyme that converts androgen precursors into estrogens.
The ovarian production of estradiol is commonly explained using the two-cell, two-gonadotropin model. Two follicular cell populations and two pituitary gonadotropins cooperate to produce estrogen efficiently.
| Component | Primary Stimulus | Major Function |
|---|---|---|
| Theca interna cell | LH | Produces androgen precursors |
| Granulosa cell | FSH | Converts androgens into estrogens through aromatase |
LH binds receptors on theca interna cells and promotes steroidogenesis. Cholesterol is converted through a series of enzymatic reactions into androgen precursors, particularly androstenedione and testosterone.
These steroids can diffuse into the neighboring granulosa compartment.
FSH binds receptors on granulosa cells and stimulates mechanisms supporting follicular growth and estrogen production.
One of its important effects is increased aromatase activity, enabling granulosa cells to convert theca-derived androgens into estrogens.
Aromatase is the enzyme complex responsible for conversion of androgen substrates into estrogens.
Important conversions include androstenedione to estrone and testosterone to estradiol.
| Step | Process |
|---|---|
| 1 | LH stimulates theca interna cells |
| 2 | Theca cells synthesize androgen precursors |
| 3 | Androgens diffuse into granulosa cells |
| 4 | FSH promotes granulosa-cell aromatase activity |
| 5 | Androgens are converted into estrogens |
| 6 | Estradiol enters follicular fluid and the circulation |
Theca and granulosa cells possess complementary steroidogenic capabilities. Theca cells can efficiently produce androgen precursors but do not provide the complete aromatase-dependent pathway required for follicular estrogen production.
Granulosa cells possess aromatase activity but depend substantially on androgen substrates generated by neighboring theca cells during follicular development.
During the follicular phase of the ovarian cycle, developing follicles produce increasing amounts of estradiol.
As a dominant follicle emerges, its granulosa cell population expands and its capacity for estrogen synthesis increases substantially.
The dominant follicle becomes the major ovarian source of estradiol during the late follicular phase.
Increasing estradiol concentrations contribute to proliferation of the endometrium and regulate hypothalamic-pituitary gonadotropin secretion.
Estradiol concentrations rise as the dominant follicle approaches maturity. Sustained high estradiol during the late follicular phase changes its feedback effect on the hypothalamic-pituitary reproductive axis.
This transition is essential for generation of the preovulatory LH surge.
During much of the ovarian cycle, estrogen contributes to negative feedback on the hypothalamus and anterior pituitary.
This feedback helps regulate GnRH-dependent gonadotropin secretion and prevents inappropriate excessive stimulation of the ovaries.
During the late follicular phase, sustained high estradiol concentrations produce positive feedback within the hypothalamic-pituitary-gonadal axis.
This promotes the marked increase in LH secretion known as the LH surge.
The LH surge initiates major changes within the mature follicle, including resumption of oocyte maturation, luteinization, enzymatic remodeling of the follicular wall, and ultimately ovulation.
The estradiol-induced transition from negative to positive feedback is therefore a critical endocrine event linking follicular maturation with ovulation.
Ovulation is the release of the secondary oocyte and associated cumulus cells from the mature ovarian follicle.
Following ovulation, the remaining follicular cells undergo luteinization and form the corpus luteum.
The corpus luteum is a temporary endocrine structure formed from the postovulatory follicle. It produces progesterone, estrogen, and inhibin.
Although progesterone becomes the dominant steroid hormone of the luteal phase, estrogen production continues.
During the luteal phase, the corpus luteum secretes estradiol together with progesterone. These hormones provide negative feedback to the hypothalamus and anterior pituitary.
This suppresses gonadotropin secretion and helps prevent recruitment of another dominant follicle during the same cycle.
If pregnancy does not occur, the corpus luteum undergoes regression. Ovarian progesterone and estrogen concentrations subsequently decrease.
The fall in ovarian steroid hormones contributes to menstruation and removes negative feedback on the hypothalamic-pituitary system, permitting the next ovarian cycle to begin.
| Phase | Estrogen Pattern | Major Source |
|---|---|---|
| Early follicular | Relatively low, then increasing | Developing follicles |
| Late follicular | Marked rise | Dominant follicle |
| Preovulatory | Sustained high estradiol | Mature dominant follicle |
| Luteal | Moderate secondary elevation | Corpus luteum |
| Late luteal without pregnancy | Falls | Regression of corpus luteum |
Estrogen has a major role in regulating the endometrium of the uterus. During the follicular phase of the ovarian cycle, increasing estrogen promotes the proliferative phase of the endometrial cycle.
Endometrial glands, stromal cells, and the vascular compartment undergo growth and remodeling under estrogenic influence.
The proliferative phase follows menstruation and corresponds broadly with the ovarian follicular phase.
Estradiol stimulates regeneration and thickening of the functional layer of the endometrium.
Estrogen promotes expression of progesterone receptors in several reproductive tissues, preparing these tissues to respond appropriately to progesterone after ovulation.
This is an important example of a permissive interaction between endocrine hormones.
Estrogen influences the cervical epithelium and cervical mucus. Around the preovulatory period, estrogenic stimulation produces mucus characteristics that facilitate sperm passage through the cervix.
Estrogen supports maturation and maintenance of the vaginal epithelium. It promotes epithelial proliferation and accumulation of glycogen within superficial epithelial cells.
Changes in estrogen exposure therefore produce recognizable changes in vaginal epithelial structure.
Estrogen influences the epithelium and muscular activity of the uterine tubes, contributing to the reproductive environment involved in gamete and early embryo transport.
Estrogen contributes to development of the breasts, particularly growth and branching of the ductal system and deposition of adipose and connective tissue during puberty.
Breast development depends on interactions among estrogen, progesterone, growth hormone, prolactin, and other hormonal signals.
Increasing ovarian estrogen secretion during puberty contributes to development of female secondary sexual characteristics.
These include characteristic patterns of breast development, body composition, skeletal maturation, and reproductive tract growth.
Activation of the hypothalamic-pituitary-gonadal axis during puberty increases gonadotropin stimulation of the ovaries and ovarian estrogen production.
Estrogen subsequently promotes maturation of the uterus, uterine tubes, vagina, external reproductive structures, breasts, and skeleton.
Estrogen is an important regulator of skeletal growth and bone remodeling. It contributes to acquisition and maintenance of bone mass and limits excessive bone resorption.
Estrogen deficiency is therefore associated with increased bone turnover and progressive loss of bone mass.
Estrogen contributes importantly to maturation and eventual closure of the epiphyseal growth plates in both females and males.
This demonstrates that estrogen has important physiological functions in both sexes.
Estrogen influences signaling pathways controlling osteoclast formation and activity. Adequate estrogen exposure helps restrain excessive bone resorption.
Loss of estrogen after menopause shifts bone remodeling toward greater net bone loss.
Estrogen receptors are present in vascular and cardiac tissues. Estrogen can influence vascular function, lipid metabolism, endothelial signaling, and other cardiovascular processes.
These actions are complex and vary with age, tissue, hormonal environment, and physiological state.
Estrogen affects hepatic synthesis of numerous plasma proteins. These include several hormone-binding proteins, coagulation-related proteins, and other circulating molecules.
Hepatic effects are particularly relevant when estrogen exposure changes substantially or when estrogen is administered pharmacologically.
Estrogen can increase hepatic production of proteins such as sex hormone-binding globulin, thyroxine-binding globulin, and corticosteroid-binding globulin.
Changes in these proteins can alter measured total concentrations of their associated hormones.
Estrogen influences adipose tissue distribution and metabolism. Changes in estrogen concentrations across puberty, reproductive life, and menopause contribute to changes in body fat distribution and metabolic physiology.
Estrogen receptors are distributed in multiple regions of the central nervous system. Estrogen influences hypothalamic reproductive regulation and can modify neural functions involving behavior, thermoregulation, cognition, and other processes.
Its neurological effects involve both classical nuclear receptor pathways and other signaling mechanisms.
Estrogens exert many of their effects through estrogen receptors, which belong to the nuclear receptor superfamily.
The major classical estrogen receptors are ERα and ERβ, encoded by different genes and expressed in overlapping but distinct patterns among tissues.
Estrogen receptor alpha (ERα) is expressed in numerous estrogen-responsive tissues and has major roles in reproductive physiology, breast tissue, bone, hypothalamic-pituitary function, and other systems.
Estrogen receptor beta (ERβ) has a different but overlapping tissue distribution and contributes to estrogen signaling in reproductive and nonreproductive tissues.
The balance of receptor subtypes can influence the response of individual tissues to estrogen.
Estradiol can diffuse across the plasma membrane and bind intracellular estrogen receptors. Hormone-receptor complexes interact with chromatin and transcriptional regulatory proteins to modify gene expression.
These genomic effects can alter protein synthesis and cellular function over relatively prolonged periods.
Activated estrogen receptors can regulate transcription through interactions with specific DNA sequences known as estrogen response elements and through interactions with other transcription factors.
The resulting transcriptional response varies according to cell type and chromatin environment.
Some estrogen effects occur more rapidly than classical changes in gene transcription and involve membrane-associated receptors and intracellular signaling pathways.
These mechanisms add to the diversity of estrogen responses among tissues.
Estrogen does not produce identical effects in every estrogen-responsive tissue. Tissue specificity depends on receptor subtype, receptor abundance, transcriptional cofactors, local hormone metabolism, developmental state, and interaction with other signaling pathways.
Estrogens are lipid-soluble steroid hormones and circulate partly bound to plasma proteins.
Important binding proteins include sex hormone-binding globulin (SHBG) and albumin. Only a relatively small fraction of circulating estradiol is unbound.
Protein-bound and free estrogen exist in reversible equilibrium. The free fraction is immediately available for many forms of tissue uptake and metabolism.
Changes in SHBG concentration can alter the relationship between total and free estrogen concentrations.
Estrogens undergo metabolism in the liver and other tissues. Metabolic pathways include interconversion among estrogenic compounds and conjugation reactions that increase water solubility.
Conjugated metabolites can subsequently be eliminated through urine or bile.
Estrogen production is not restricted to the ovaries. Aromatase is expressed in several peripheral tissues, including adipose tissue, where androgen precursors can be converted into estrogens.
Peripheral aromatization becomes particularly important when ovarian estrogen production declines.
Estrogen is also physiologically important in males. A portion of circulating and locally acting estrogen is produced through aromatization of testosterone and other androgen precursors.
Estrogen contributes importantly to bone physiology, reproductive function, and regulation of the hypothalamic-pituitary-gonadal axis in males.
Pregnancy is associated with a major increase in estrogen production. The placenta becomes an important endocrine organ and produces large quantities of estrogens using steroid precursors derived substantially from fetal and maternal sources.
Estriol becomes especially prominent during pregnancy.
The production of pregnancy-associated estrogens illustrates cooperation among maternal, placental, and fetal tissues.
The placenta lacks the complete enzymatic capacity to synthesize all required androgen precursors independently and therefore uses precursors supplied through the fetoplacental system.
Following menopause, depletion of functional ovarian follicles causes a major reduction in cyclic ovarian estradiol production.
Peripheral conversion of adrenal and other androgen precursors becomes a relatively more important source of circulating estrogen, particularly estrone.
Reduced ovarian estrogen and inhibin secretion decreases negative feedback on the hypothalamic-pituitary axis.
As a result, circulating gonadotropin concentrations, particularly FSH, increase after menopause.
Reduced estrogen activity can affect multiple tissues because estrogen receptors are widely distributed.
Important physiological consequences can involve reproductive tissues, bone, thermoregulation, urogenital tissues, and other systems.
Excessive estrogenic activity may result from endogenous hormone production, peripheral conversion, hormone-producing lesions, altered metabolism, or exogenous estrogen exposure.
The resulting effects depend on age, sex, reproductive state, duration of exposure, and target-tissue responsiveness.
Because aromatase is required for estrogen synthesis from androgen precursors, changes in aromatase activity can substantially alter estrogen availability.
Aromatase activity is therefore an important regulatory point in ovarian and peripheral estrogen physiology.
Estrogen participates in regulation of the hypothalamic-pituitary-gonadal axis. Its feedback effects vary according to concentration, duration of exposure, and reproductive context.
| Estrogen State | Typical Feedback Effect |
|---|---|
| Low to moderate concentrations during much of cycle | Predominantly negative feedback |
| Sustained high estradiol during late follicular phase | Positive feedback leading to gonadotropin surge |
| Luteal phase estrogen with progesterone | Predominantly negative feedback |
Estrogen influences neural networks controlling hypothalamic GnRH secretion. Much of this regulation occurs through upstream neurons rather than simple direct control of GnRH neurons alone.
Kisspeptin-containing neuronal populations are particularly important in the integration of sex-steroid feedback.
Kisspeptin is an important regulator of GnRH neurons and participates in both pulsatile reproductive signaling and the mechanisms that permit the preovulatory gonadotropin surge.
Estrogenic effects on kisspeptin-related pathways contribute to changes in reproductive feedback across the ovarian cycle.
Estrogen contributes to regulation of FSH secretion, but FSH is also strongly influenced by ovarian inhibins and activins.
The combination of these signals helps coordinate follicular recruitment and selection during the ovarian cycle.
Estradiol contributes to suppression of LH secretion during much of the cycle but becomes essential for generation of the midcycle LH surge when sustained at sufficiently high concentrations during the late follicular phase.
Estrogen supports growth and maintenance of reproductive structures, particularly during puberty and the reproductive years.
Target tissues include the uterus, uterine tubes, vagina, external reproductive tissues, and mammary glands.
Estrogen supports epithelial integrity and vascularity within portions of the lower reproductive and urinary tracts.
Reduced estrogen after menopause can therefore produce structural and functional changes in these tissues.
Estrogen receptors are present within skin and associated tissues. Estrogen can influence collagen, connective tissue, vascular characteristics, and other aspects of skin physiology.
During puberty, estrogen contributes to the pubertal growth pattern while also promoting eventual epiphyseal maturation.
Its skeletal effects occur in interaction with growth hormone, IGF-1, and other hormonal signals.
Adult bone is continuously remodeled by coordinated activity of osteoclasts and osteoblasts. Estrogen helps maintain balance within this remodeling system.
Declining estrogen after menopause increases bone resorption and contributes to age-related osteoporosis risk.
Estrogen influences hepatic lipid metabolism and circulating lipoprotein patterns. These effects vary with the hormonal environment and route of exposure.
The systemic consequences of estrogen therefore extend well beyond reproductive anatomy.
Estrogen can influence hepatic production of proteins involved in coagulation and fibrinolysis.
This effect is particularly relevant to pharmacological estrogen exposure and demonstrates the broad hepatic actions of steroid hormones.
Estrogen acts within a network of other endocrine signals. Its effects interact with progesterone, gonadotropins, growth hormone, prolactin, androgens, thyroid hormones, glucocorticoids, and metabolic hormones.
Reproductive physiology therefore cannot be understood from estrogen concentration alone.
Estrogen and progesterone have coordinated but distinct actions within reproductive tissues. Estrogen promotes proliferative growth of the endometrium and induces progesterone receptor expression, while progesterone subsequently promotes secretory differentiation after ovulation.
Granulosa cells produce inhibins in addition to estrogen. Inhibin contributes to selective regulation of pituitary FSH secretion.
These signals work together to coordinate follicular development and hypothalamic-pituitary feedback.
| Structure or Factor | Role |
|---|---|
| Anterior pituitary | Produces LH and FSH |
| LH | Stimulates theca-cell androgen synthesis |
| Theca interna | Provides androgen precursors |
| FSH | Promotes granulosa-cell aromatase activity |
| Granulosa cells | Convert androgen precursors to estrogens |
| Aromatase | Converts androgens into estrogens |
| Dominant follicle | Major source of preovulatory estradiol |
| Corpus luteum | Produces estrogen during luteal phase along with progesterone |
| Target | Important Effects |
|---|---|
| Hypothalamus and pituitary | Negative and positive feedback regulation of reproductive axis |
| Ovary | Participates in follicular development and intraovarian regulation |
| Uterus | Promotes endometrial proliferation and reproductive tract growth |
| Cervix | Modifies cervical mucus and epithelium |
| Vagina | Supports epithelial maturation |
| Breast | Promotes ductal development |
| Bone | Supports bone mass and epiphyseal maturation |
| Liver | Modifies synthesis of multiple plasma proteins |
| Brain | Participates in reproductive, behavioral, and neuroendocrine regulation |
| Feature | Key Point |
|---|---|
| Hormone class | Steroid hormone |
| Major ovarian estrogen | Estradiol |
| Principal ovarian source | Developing follicles and corpus luteum |
| Follicular estrogen-producing cells | Granulosa cells using theca-derived androgen substrates |
| Major regulatory hormones | FSH and LH |
| Key synthetic enzyme | Aromatase |
| Major receptors | ERα and ERβ |
| Blood transport | Bound partly to SHBG and albumin |
| Feedback | Can produce negative or positive feedback depending on physiological context |
| Major reproductive actions | Follicular-cycle regulation, reproductive tract maintenance, endometrial proliferation, and secondary sexual development |
Estrogen physiology illustrates the close integration of ovarian anatomy with hypothalamic and pituitary endocrine regulation. Estrogen synthesis within the developing follicle requires cooperation between two anatomically distinct follicular cell populations. LH-responsive theca interna cells generate androgen substrates, while FSH-responsive granulosa cells convert those substrates into estrogens through aromatase.
As the dominant follicle develops, increasing granulosa-cell mass and steroidogenic activity produce progressively greater estradiol secretion. Estradiol then acts locally within the ovary, systemically on reproductive and nonreproductive tissues, and centrally on the hypothalamic-pituitary axis. The resulting feedback changes are essential for coordinating follicular maturation with the timing of ovulation.
Estrogen target tissues are widely distributed because estrogen receptors are expressed throughout many organ systems. The reproductive tract, breast, skeleton, brain, liver, cardiovascular tissues, skin, and adipose tissue can all respond to estrogenic signals. The precise response varies according to receptor subtype, receptor abundance, local metabolism, transcriptional cofactors, and physiological state.
The decline in ovarian estrogen production after menopause demonstrates the systemic importance of these hormones. Reduced estrogen exposure affects reproductive and urogenital tissues, skeletal remodeling, hypothalamic regulation, and other physiological systems. At the same time, peripheral aromatization continues to provide a source of estrogen, particularly estrone.
Estrogen is therefore not simply an ovarian reproductive hormone. It is a widely acting endocrine signal whose production depends on specialized ovarian cellular anatomy and whose effects integrate reproductive cycling, hypothalamic-pituitary regulation, skeletal physiology, development, and the function of numerous target tissues throughout the body.